Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Amicus Therapeutics Inc. logo

Amicus Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

9.47
 
USD
  
-0.25
  
(-2.57%)
Optionable: Yes  Market Cap: 2,935 M  90-day average vol: 2,867,468

Previous close: 9.72  Open: 9.73  Bid: 9.32  Ask: 9.65
52 week range    
9.02   
   14.57
Peers   
BIIB / 
GSK / 
ESPR / 
BMRN / 
NVO / 
Last updated: Friday 24th May 2024
40
MarketXLS Rank
40
Value
23
Technical
57
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BIIB

34 B21.6221.3

BMRN

16 B886.389.37

ESPR

0 B-0.43.42

GSK

LXRX

0 B-6.73.1

NVO

Financials

FOLD Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles198 M198 M198 M198 M198 M
Basic EPS from continuing operations-1.48-1.07-0.92-0.82-0.51
Basic EPS total-1.48-1.07-0.92-0.82-0.51
Basic weighted shares outstanding74 M110 M134 M153 M186 M240 M259 M271 M289 M295 M
Cost of sales-833000.0-6 M-14 M22 M31 M34 M39 M37 M
Depreciation2 M2 M3 M4 M4 M5 M9 M6 M5 M8 M
Depreciation unreconciled2 M2 M3 M4 M4 M5 M9 M6 M5 M8 M
DepreciationAndAmortization2 M2 M3 M4 M4 M5 M9 M6 M5 M8 M
Diluted EPS total-0.93-1.2-1.49-1.85-1.88-1.48-1.07-0.92-0.82-0.51
Diluted normalized net income/share-0.92-0.82-0.51
Diluted weighted shares outstanding74 M110 M134 M154 M186 M240 M271 M289 M295 M
GainOnSaleOfSecurity50000.032000.0-3 M
GeneralAndAdministrativeExpense21 M-3 M-3 M-4 M-6 M170 M156 M193 M213 M275 M
Gross operating profit1 M4 M31 M77 M160 M230 M271 M291 M362 M
ImpairmentOfCapitalAssets465 M7 M1 M
Income before tax-70 M-132 M-204 M-449 M-349 M-356 M-274 M-242 M-242 M-150 M
Income restructuring and M&A-63000.015000.069000.0
Income taxes-1 M952000.010 M-165 M-94000.0478000.03 M9 M-5 M1 M
Interest income223000.0929000.02 M4 M10 M10 M3 M509000.03 M7 M
InterestExpenseNonOperating1 M2 M5 M17 M22 M19 M22 M32 M37 M50 M
InterestExpenseOperating-208000.030 M34 M48 M
MiscOtherSpecialCharges-177000.0-4 M-12 M277 M82 M-3 M-8 M-3 M4 M-30 M
Net income from total operations-69 M-132 M-200 M-284 M-349 M-356 M-277 M-250 M-237 M-152 M
NetIncomeCommonStockholders-69 M-132 M-200 M-284 M-349 M-316 M-277 M-250 M-237 M-152 M
NetIncomeContinuousOperations-69 M-132 M-200 M-284 M-349 M-356 M-277 M-250 M-237 M-152 M
NetNonOperatingInterestIncomeExpense-1 M-649000.0-4 M-13 M-12 M-9 M-19 M-32 M-34 M-43 M
Normalized income-117 M
Operating income-69 M-126 M-175 M-248 M-417 M-304 M-247 M-206 M-212 M-77 M
Operating income before depreciation (EBITDA)-67 M-129 M-195 M-419 M-311 M-330 M-241 M-170 M-162 M-42 M
OperatingExpense-70 M-130 M-186 M-473 M-406 M464 M477 M477 M503 M439 M
Other income net177000.04 M12 M-277 M-80 M6 M11 M10 M-3 M32 M
OtherGandA21 M-3 M-3 M-4 M-6 M170 M156 M193 M213 M275 M
OtherImpairmentOfCapitalAssets-464 M
OtherOperatingExpenses11 M11 M10 M10 M10 M
RentAndLandingFees21 M-3 M-3 M-4 M-6 M
Research & development expense48 M77 M105 M149 M271 M286 M308 M272 M277 M152 M
ResearchExpense48 M77 M105 M149 M271 M286 M308 M272 M277 M152 M
RestructringAndMnAIncome-63000.015000.069000.0
Revenue per share-248000.0198 M198 M199 M2 M199 M
SalariesAndWages-6 M-10 M-18 M-23 M-29 M
Selling Gen & administrative expense21 M47 M71 M89 M127 M170 M156 M193 M213 M275 M
SellingAndMarketingExpense47 M71 M89 M127 M
SellingExpense47 M71 M89 M127 M
Special income/charges63000.0-15000.0-69000.0-465 M-7 M-1 M
Total Income available for interest expense (EBIT)-69 M-131 M-199 M-432 M-327 M-337 M-252 M-179 M-170 M-52 M
Total common shares outstanding96 M125 M195 M187 M224 M257 M264 M283 M295 M
Total net income-69 M-132 M-200 M-284 M-349 M-356 M-277 M-250 M-237 M-152 M
Total ordinary shares296 M296 M296 M296 M296 M296 M296 M296 M296 M296 M
Total revenues1 M5 M37 M91 M182 M261 M306 M329 M399 M
TotalExpenses-70 M-130 M-187 M-479 M-420 M486 M508 M512 M541 M477 M
TotalRevenue1 M5 M37 M91 M182 M261 M306 M329 M399 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University